Related Experiment Video
Updated: Jun 4, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
HIV entry inhibitors: progress in development and application
Wei-hong Lai1, Li Huang, Chin-ho Chen
1Department of Surgery, Duke University Medical Center, Surgical Oncology Research Facility, Durham, North Carolina 27710, USA.
Abstract:
This review discusses recent progress in the development of anti-HIV agents, with emphasis on small molecule HIV-1 entry inhibitors. The entry inhibitors primarily target HIV-1 envelope glycoproteins or the cellular receptors, CD4 and chemokine receptors. Two of the entry inhibitors, enfuvirtide and maraviroc, have been approved by the US FDA for AIDS therapy. The drug resistance associated with some of the entry inhibitors will also be discussed.
More Related Videos
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Retrovirus Life Cycles
Inhibitors Of Virion Release
Sexually Transmitted Infections

